If you read the last statement on merger news, it clearly states that the OTCBB board is temporary. Key word "initially". I don't think it jumps to the NYSE...maybe Nasdaq would be the wiser move. I hope that they discuss this when this merger is completed.
The structure of the transaction will be in the form of a reverse merger with Cocrystal Pharma, Inc. as the surviving corporation and will now be headquartered in Bothell, WA. The combined company will initially continue to trade on the OTCBB under the symbol BZNE.
As usual I am only competent to comment on Lakewood's assessment of Rayaldy, OPKO's vitamin D drug. In their article, Lakewood despairingly referred to me as a psychiatrist, which is true. They could have also accurately referred to me as an emergency room physician or a GP, both of which I have been in my career. The fact is I have been the executive director of the Vitamin D Council for 11 years, during which time I written and published more than 15 peer reviewed scientific articles on vitamin D, three of which are the most cited articles in the history of their respectful journals.
It is also true that I am a retail investor and not a professional investor, a point I made clear in my article. I am not an expert in investing; I am an expert in vitamin D.
I found it interesting that Lakewood did not argue that Rayaldy will fail to get FDA approval; they seemed to accept that as a foregone conclusion. I agree. The phase 2 trials were so positive and the FDA's interest in the drug so obvious, I agree with Lakewood implicit admission that Rayaldy will be on the market sometime in 2015.
What I disagree with, and what any vitamin D expert will confirm, is what drug will compete with Rayaldy? Lakewood asserts it will be over the counter (OTC) vitamin D3, which is available now. If Lakewood's contention were true, kidney failure patients would already be taking OTC vitamin D and they are not. The fact is that OTC drugs simply do not compete with prescription drugs and never have. Both patients and doctors expect a prescription after an expensive consultation, an unfortunate fact of modern medical care and one the FDA implicitly acknowledged by fast tracking Rayaldy.
Lakewood also contends that prescription activated vitamin D (calcitriol) marketed under trade names Rocaltrol (Roche) and Calcijex (Abbott), or similar calcitriol analogues, like Hectoral, will compete with Rayaldy.
This may be the case for the few nephrologists who have not kept up with the current s
Did Randy Harl call Spandex & Spurs out. Stated that a new MSA announcement in a couple of weeks. States that oil and gas will return to 2008/2009 profitability.
Gophers do not fear anyone wearing spandex and spurs holding a shovel. Bad call on selling yesterday for you.
I'm sure you immediately gratify yourself at every opportunity. As for Pr's, they could settle the lawsuit with WPRP, they could announce the other two MSA contracts. All the storm damage lately could add to the bottom line for 2013. Granted this doesn't have all the bells ands whistles that you get wearing spandex and spurs.
They give a presentation today, I plan on listening to it. Hopefully they hint at some things. You can preview the slide show early.
You like to make things up. That way you don't have to look in the mirror. As for finding WG, I had read a piece on growth of LNG and looked around to see who may get a piece of the build out. If I have 300 id's, why haven't any of them shown up to help me expose you? Don't you worry about me, you the idiot with several posts that were material inaccurate. You hate the name spandex and spurs. Good. Floor trader...only if you mean I wash the floor with you. Attitude only comes with nonsense, which you need the stretchy pants to house all of it.
A little premature goldilocks. Maybe Cocrystals is working on something for what ails you. So when the moments right, kind of thing. Impressive how fast she rebounded.
Pie Five has 13 locations in Texas, two each in Kansas and Utah, and one in North Carolina. More than 150 franchise units are currently under contract in Florida, Kansas, Kentucky, Maryland, Missouri, North Carolina, Oklahoma, Tennessee, Texas, Utah, Virginia and Washington, DC.
Sentiment: Strong Buy
We know why you wear spandex and spurs! You love the stretchy pants. Do you concur?
I got a great New Years Resolution for you spandex. 2014 you stop filling the stretchy pants with bull _hit.
Over the years? I only recently bought this stock. I haven't said anything nasty. I just correct misinformation. It would be nice if they hint at what growth would be in the modular unit division. My guess 2014 nets out $200M in business. Has a 10% margin or better. I also believe this is how we get,to doing $4B a year and 5% profit margin.
In your wet dreams will this hit the $6's. The CFO's buy has been well discussed. I also exposed the lawsuit winnable inaccuracy, believe you part took in that one. It seems we have a few posters here who go out of their way to discredit a company that would be very profitable, if not for the MPRP contract.
I just calculated the profit margins each division enjoys:
Utility 5.85% on $349M sales for 9 months
Canada 7.98% on $24M sales for 9 months
Professional services 5.71% on 252M sales for 9 months
Oil and Gas a loss of $42M for 9 months. What would our IS look like if Oil and gas had not had the MPRP fiasco. The loss should have been a profit had things gone as planned with MPRP. However the bleeding has stopped in Oil and Gas. Probably has done a needed turn around this quarter. They lost an average of $16.6M in each of the first two quarters and in the 3Q that slowed to $8.8M. At some point MPRP bleed be through. If you read the article I posted on the lawsuit, the spokes person for MPRP stated WG had done a very good job and they expected the settlement would impact their utility customers would be modestly impacted on the bills.
I feel strongly that a few investors here would love to buy lower and will use whatever means to distort. I'd be careful trying to time this one. Large contracts are awarded everyday and the bad news is behind this one. Canada is growing by leaps and bounds. Last quarter it produced a $11M profit before taxes and interest. Compare that with the first two quarters profits average of $7.4M.
Backlog excellent, MPRP behind us, sell of Hawkeye, settlement of MRRP, modular unit story unfolding, Gulf coast and natural gas growth, panama canal shipping. I believe that our growth is well intact for all of 2014. This company could easily make $100M next year. $2 a share.
I hear this all the time about pitching PI and although they make no profit off it, it does pay a load of bills for this company. It paid for the 15 P5 the company owns. It pays for all the salaries, headquarters and all the fixed costs associated with P5. They would only have 2M in revenues a quarter without PI. Expenses could be near $4M without PI to help pay for them. What drags us down is the former management was happy getting a salary and doing little else to grow revenues.
Franchise stores are really not money makers. They will pay one time fee to open and maybe $36K a year in royalties. Even a 100 franchises would only generate $3.60M in revenues yearly. The key for them to see appreciation like Dominoes has, is to sell product to P5 and PI. Economies of scale is where our valuation will come from. Not from fees, that is just extra bonus. The $40M in revenues we get now is from selling product.